Recent advances in the neurobiology of alcoholism: The role of adenosine

Pharmacology and Therapeutics

Volumn 101, Issue 1, 2004, Pages 39-46

  Mailliard, William S ^a,b   Diamond, Ivan ^a,b,c  

^a UNIVERSITY OF CALIFORNIA SAN FRANCISCO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adenosine; Dopamine; Ethanol; Nucleus accumbens; PKA; Synergy

Indexed keywords

ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ALCOHOL; BETA ADRENERGIC RECEPTOR; BW 1434U; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DIMER; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; GUANINE NUCLEOTIDE BINDING PROTEIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; NITROBENZYLTHIOINOSINE; NUCLEOSIDE TRANSPORTER; PERTUSSIS TOXIN; PROTEIN KINASE C ALPHA; PROTEIN SUBUNIT; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG;

ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOL INTOXICATION; ALCOHOL METABOLISM; ALCOHOLISM; BLOOD BRAIN BARRIER; CELL CULTURE; CELLULAR DISTRIBUTION; DNA RESPONSIVE ELEMENT; DRINKING BEHAVIOR; GENE DELETION; GENE EXPRESSION; GENETIC ENGINEERING; GENETIC TRANSCRIPTION; GENETICS; GOLGI COMPLEX; HUMAN; LIVER; MESOLIMBIC DOPAMINERGIC SYSTEM; NERVE CELL; NEUROBIOLOGY; NEUROTRANSMISSION; NUCLEUS ACCUMBENS; PATHOPHYSIOLOGY; PHOSPHORYLATION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VENTRAL TEGMENTUM;

EID: 0346056792     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2003.10.002     Document Type: Review

References (78)

1. Abel T., Nguyen P.V., Barad M., Deuel T.A.S., Kandel E.R. Genetic demonstration of a role for PKA in the late phase of LTP and in hippocampus-based long-term memory. Cell. 88:1997;615-626.
2. Appel S.B., Liu Z., McElvain M.A., Brodie M.S. Ethanol excitation of dopaminergic ventral tegmental area neurons is blocked by quinidine. J Pharmacol Exp Ther. 306:2003;437-446.
3. Asai K., Ishii A., Yao L., Diamond I., Gordon A.S. Varying effects of ethanol on transfected cell lines. Alcohol Clin Exp Res. 22(1):1998;163-166.
4. Asher O., Cunningham T.D., Yao L., Gordon A.S., Diamond I. Ethanol stimulates cAMP-responsive element (CRE)-mediated transcription via CRE-binding protein and cAMP-dependent protein kinase. J Pharmacol Exp Ther. 301:2002;66-70.
5. Baker L.P., Nielsen M.D., Impey S., Hacker B.M., Poser S.W., Chan M.Y.M., Storm D.R. Regulation and immunohistochemical localization of βγ-stimulated adenylyl cyclases in mouse hippocampus. J Neurosci. 19:1999;180-192.
6. Berke J.D., Hyman S.E. Addiction, dopamine, and the molecular mechanisms of memory. Neuron. 25:2000;515-532.
7. 1-14C]acetate in caudate nucleus, thalamus and motor cortex (CAT). Brain Res. 12:1969;444-455.
8. Campisi P., Carmichael F.J.L., Crawford M., Orrego H., Khanna J.M. Role of adenosine in the ethanol-induced potentiation of the effects of general anesthetics in rats. Eur J Pharmacol. 325:1997;165-172.
9. Carmichael F.J., Israel Y., Saldivia V., Giles H.G., Meggiorini S., Orrego H. Blood acetaldehyde and the ethanol-induced increase in splanchnic circulation. Biochem Pharmacol. 36:1987;2673-2678.
10. 2-adenosine receptors. Am J Physiol. 255:1988;G417-G423.
11. Carmichael F.J., Israel Y., Crawford M., Minhas K., Saldivia V., Sandrin S., Campisi P., Orrego H. Central nervous system effects of acetate: contribution to the central effects of ethanol. J Pharmacol Exp Ther. 259:1991;403-408.
12. Cass C.E., Young J.D., Baldwin S.A. Recent advances in the molecular biology of nucleoside transporters of mammalian cells. Biochem Cell Biol. 76:1998;761-770.
13. Charness M.E., Querimit L.A., Henteleff M. Ethanol differentially regulates G proteins in neural cells. Biochem Biophys Res Commun. 155:1988;138-143.
14. Coe I.R., Dohrman D.P., Constantinescu A., Diamond I., Gordon A.S. Activation of cyclic AMP-dependent protein kinase reverses tolerance of a nucleoside transporter to ethanol. J Pharmacol Exp Ther. 276:1996;365-369.
15. Constantinescu A., Diamond I., Gordon A.S. Ethanol-induced translocation of cAMP-dependent protein kinase to the nucleus. Mechanism and functional consequences. J Biol Chem. 274:1999;26985-26991.
16. Constantinescu A., Gordon A.S., Diamond I. cAMP-dependent protein kinase types I and II differentially regulate cAMP response element-mediated gene expression: implications for neuronal responses to ethanol. J Biol Chem. 277:2002;18810-18816.
17. Cornford E.M., Oldendorf W.H. Independent blood-brain barrier transport systems for nucleic acid precursors. Biochim Biophys Acta. 394:1975;211-219.
18. Cunningham C.L., Howard M.A., Gill S.J., Rubinstein M., Low M.J., Grandy D.K. Ethanol-conditioned place preference is reduced in dopamine D2 receptor-deficient mice. Pharmacol Biochem Behav. 67:2000;693-699.
19. Dar M.S. Modulation of ethanol-induced motor incoordination by mouse striatal A(1) adenosinergic receptor. Brain Res Bull. 55:2001;513-520.
20. Diamond I., McIntire S. Alcohol neurotoxicity. Asbury A.K., McKhann G., McDonald W.I., Goadsby P.J., McArthur J.C. Diseases of the Nervous System. 2002;1814-1826 WB Saunders, Philadelphia.
21. Dohrman D.P., Diamond I., Gordon A.S. Ethanol causes translocation of cAMP-dependent protein kinase catalytic subunit to the nucleus. Proc Natl Acad Sci USA. 93:1996;10217-10221.
22. Dohrman D.P., Chen H.M., Gordon A.S., Diamond I. Ethanol-induced translocation of protein kinase A occurs in two phases: control by different molecular mechanisms. Alcohol Clin Exp Res. 26:2002;407-415.
23. Dunwiddie T.V., Masino S.A. The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci. 24:2001;31-55.
24. Federman A.D., Conklin B.R., Schrader K.A., Reed R.R., Bourne H.R. Hormonal stimulation of adenylyl cyclase through Gi-protein beta gamma subunits. Nature. 356:1992;159-161.
25. Ferre S., O'Connor W.T., Fuxe K., Ungerstedt U. The striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain. J Neurosci. 13:1993;5402-5406.
26. Ferre S., O'Connor W.T., Snaprud P., Ungerstedt U., Fuxe K. Antagonistic interaction between adenosine A2A receptors and dopamine D2 receptors in the ventral striopallidal system. Implications for the treatment of schizophrenia. Neuroscience. 63:1994;765-773.
27. 2 dopamine receptors in rat striatum. Mol Brain Res. 14:1992;186-195.
28. Franco R., Ferre S., Agnati L., Torvinen M., Gines S., Hillion J., Casado V., Lledo P., Zoli M., Lluis C., Fuxe K. Evidence for adenosine/dopamine receptor interactions: indications for heteromerization. Neuropsychopharmacology. 23:2000;S50-S59.
29. 3H]SCH 58261, a selective adenosine A2A receptor antagonist, is a useful ligand in autoradiographic studies. J Neurochem. 70:1998;1210-1216.
30. Gordon A.S., Collier K., Diamond I. Ethanol regulation of adenosine receptor-stimulated cAMP levels in a clonal neural cell line: an in vitro model of cellular tolerance to ethanol. Proc Natl Acad Sci USA. 83:1986;2105-2108.
31. Harper J.F., Brooker G. Alcohol potentiation of isoproterenol-stimulated cyclic AMP accumulation in rat parotid. J Cyclic Nucleotide Res. 6:1980;51-62.
32. Hassan S., Duong B., Kim K.-S., Miles M.F. Pharmacogenomic analysis of mechanisms mediating ethanol regulation of dopamine beta-hydroxylase. J Biol Chem. 278:2003;38860-38869.
33. Hodge C.W., Samson H.H., Chappelle A.M. Alcohol self-administration: further examination of the role of dopamine receptors in the nucleus accumbens. Alcohol Clin Exp Res. 21:1997;1083-1091.
34. Hyman S.E., Malenka R.C. Addiction and the brain: the neurobiology of compulsion and its persistence. Nat Rev Neurosci. 2:2001;695-703.
35. Inglese J., Luttrell L.M., Iniguez-Lluhi J.A., Touhara K., Koch W.J., Lefkowitz R.J. Functionally active targeting domain of the beta-adrenergic receptor kinase: an inhibitor of G beta gamma-mediated stimulation of type II adenylyl cyclase. Proc Natl Acad Sci USA. 91:1994;3637-3641.
36. Israel Y., Orrego H., Carmichael F.J. Acetate-mediated effects of ethanol. Alcohol Clin Exp Res. 18:1994;144-148.
37. 2 receptors in the rat brain. Brain Res. 484:1989;111-118.
38. Koch W.J., Hawes B.E., Inglese J., Luttrell L.M., Lefkowitz R.J. Cellular expression of the carboxyl terminus of a G protein-coupled receptor kinase attenuates G beta gamma-mediated signaling. J Biol Chem. 269:1994;6193-6197.
39. Krauss S.W., Ghirnikar R.B., Diamond I., Gordon A.S. Inhibition of adenosine uptake by ethanol is specific for one class of nucleoside transporters. Mol Pharmacol. 44:1993;1021-1026.
40. Kudlacek O., Just H., Korkhov V.M., Vartian N., Klinger M., Pankevych H., Yang Q., Nanoff C., Freissmuth M., Boehm S. The human D(2) dopamine receptor synergizes with the A(2A) adenosine receptor to stimulate adenylyl cyclase in PC12 cells. Neuropsychopharmacology. 28:2003;1317-1327.
41. Kull B., Svenningsson P., Fredholm B.B. Adenosine A2A receptors are colocalized with and activate golf in rat striatum. Mol Pharmacol. 58:2000;771-777.
42. Latini S., Pedata F. Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J Neurochem. 79:2001;463-484.
43. Lester L.B., Scott J.D. Anchoring and scaffold proteins for kinases and phosphatases. Recent Prog Horm Res. 52:1997;429-430.
44. Martinez-Mir M.I., Probst A., Palacios J.M. Adenosine A2 receptors: selective localization in the human basal ganglia and alterations with disease. Neuroscience. 42:1991;697-706.
45. Melis M., Camarini R., Ungless M.A., Bonci A. Long-lasting potentiation of GABA-ergic synapses in dopamine neurons after a single in vivo ethanol exposure. J Neurosci. 22:2002;2074-2082.
46. Mochly-Rosen D., Chang F.-H., Cheever L., Kim M., Diamond I., Gordon A.S. Chronic ethanol causes heterologous desensitization of receptors by reducing as messenger RNA. Nature. 333:1988;848-850.
47. Moore M.S., DeZazzo J., Luk A.Y., Tully T., Singh C.M., Heberlein U. Ethanol intoxication in Drosophila: genetic and pharmacological evidence for regulation by the CAMP signaling pathway. Cell. 93:1998;997-1007.
48. Nagy L.E. Role of adenosine A1 receptors in inhibition of receptor-stimulated cyclic AMP production by ethanol in hepatocytes. Biochem Pharmacol. 48:1994;2091-2096.
49. Nagy L.E., Diamond I., Collier K., Lopez L., Ullman B., Gordon A.S. Adenosine is required for ethanol-induced heterologous desensitization. Mol Pharmacol. 36:1989;744-748.
50. Nagy L.E., Diamond I., Casso D.J., Franklin C., Gordon A.S. Ethanol increases extracellular adenosine by inhibiting adenosine uptake via the nucleoside transporter. J Biol Chem. 265:1990;1946-1951.
51. Nagy L.E., Diamond I., Gordon A.S. cAMP-dependent protein kinase regulates inhibition of adenosine transport by ethanol. Mol Pharmacol. 40:1991;812-817.
52. Nestler E.J. Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci. 2:2001;119-128.
53. 3H]KF17837S, a selective adenosine A2 receptor antagonist, to rat brain membranes. Mol Pharmacol. 46:1994;817-822.
54. Obadiah J., Avidor-Reiss T., Fishburn C.S., Carmon S., Bayewitch M., Vogel Z., Fuchs S., Levavi-Sivan B. Adenylyl cyclase interaction with the D2 dopamine receptor family; differential coupling to Gi, Gz, and Gs. Cell Mol Neurobiol. 19:1999;653-664.
55. Orrego H., Carmichael F.J., Israel Y. New insights on the mechanism of the alcohol-induced increase in portal blood flow. Can J Pharmacol. 66:1988;1-9.
56. Orrego H., Carmichael F.J., Saldivia V., Giles H.G., Sandrin S., Israel Y. Ethanol-induced increase in portal blood flow: role of adenosine. Am Physiol Soc. 1988;G495-G501.
57. Pandey S.C., Saito T., Yoshimura M., Sohma H., Gotz M.E. cAMP signaling cascade: a promising role in ethanol tolerance and dependence. Alcohol Clin Exp Res. 25:2001;465-588.
58. Park S.K., Sedore S.A., Cronmiller C., Hirsh J. Type II cAMP-dependent protein kinase-deficient Drosophila are viable but show developmental, circadian, and drug response phenotypes. J Biol Chem. 275:2000;20588-20596.
59. 3H]-CGS 21680 as a ligand. Arch Pharm. 342:1990;85-89.
60. Phillips T.J., Brown K.J., Burkhart-Kasch S., Wenger C.D., Kelly M.A., Rubinstein M., Grandy D.K., Low M.J. Alcohol preference and sensitivity are markedly reduced in mice lacking dopamine D2 receptors. Nat Neurosci. 1:1998;610-615.
61. Ribeiro J.A., Sebastiao A.M., de Mendonca A. Adenosine receptors in the nervous system: Pathophysiological implications. Prog Neurobiol. 68:2003;377-392.
62. Risinger F.O., Freeman P.A., Rubinstein M., Low M.J., Grandy D.K. Lack of operant ethanol self-administration in dopamine D2 receptor knockout mice. Psychopharmacology (Berl). 152:2000;343-350.
63. Rosin D.L., Robeva A., Woodard R.L., Guyenet P.G., Linden J. Immunohistochemical localization of adenosine A2A receptors in the rat central nervous system. J Comp Neurol. 401:1998;163-186.
64. Sapru M.K., Diamond I., Gordon A.S. Adenosine receptors mediate cellular adaptation to ethanol in NG108-15 cells. J Pharmacol Exp Ther. 271:1994;542-548.
65. Schiffmann S.N., Jacobs O., Vanderhaeghen J.-J. Striatal restricted adenosine A2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study. J Neurochem. 57:1991;1062-1067.
66. Schuckit M.A. Alcohol sensitivity and dependence. EXS. 71:1994;341-348.
67. Schwartz J.H. The many dimensions of cAMP signaling. Proc Natl Acad Sci USA. 98:2001;13482-13484.
68. Sharma S.K., Klee W.A., Nirenberg M. Dual regulation of adenylyl cyclase accounts for narcotic dependence and tolerance. Proc Natl Acad Sci USA. 72:1975;3092-3096.
69. Svenningsson P., Hall H., Sedvall G., Fredholm B.B. Distribution of adenosine receptors in the postmortem human brain: an extended autoradiographic study. Synapse. 27:1997;322-335.
70. Tang W.J., Gilman A.G. Type-specific regulation of adenylyl cyclase by G protein beta gamma subunits. Science. 254:1991;1500-1503.
71. Thibault C., Lai C., Wilke N., Duong B., Olive M.F., Rahman S., Dong H., Hodge C.W., Lockhart D.J., Miles M.F. Expression profiling of neural cells reveals specific patterns of ethanol-responsive gene expression. Mol Pharmacol. 52:2000;1593-1600.
72. Thiele T.E., Willis B., Stadler J., Reynolds J.G., Bernstein I.L., McKnight G.S. High ethanol consumption and low sensitivity to ethanol-induced sedation in protein kinase A-mutant mice. J Neurosci. 20:2000;RC75-RC80.
73. Thorn J.A., Jarvis S.M. Adenosine transporters. Gen Pharmacol. 27:1996;613-620.
74. 3H]CGS 21680 to human and rat brain: evidence for multiple affinity sites. J Neurochem. 55:1990;1763-1771.
75. Wand G., Levine M., Zweifel L., Schwindinger W., Abel T. The cAMP-protein kinase A signal transduction pathway modulates ethanol consumption and sedative effects of ethanol. J Neurosci. 21:2001;5297-5303.
76. Watts V.J., Neve K.A. Sensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptors. Mol Pharmacol. 50:1996;966-976.
77. Watts V.J., Neve K.A. Activation of type II adenylate cyclase by D2 and D4 but not D3 dopamine receptors. Mol Pharmacol. 52:1997;181-186.
78. Yao L., Arolfo M.P., Dohrman D.P., Jiang Z., Fan P., Fuchs S., Janak P.H., Gordon A.S., Diamond I. Betagamma dimers mediate synergy of dopamine D2 and adenosine A2 receptor-stimulated PKA signaling and regulate ethanol consumption. Cell. 109:2002;733-743.